About Synthecon
Synthecon is a Healthcare company based in Houston (United States) founded in 1990. It designs and manufactures 3D cell culture systems. It operates in the Healthcare and Technology sectors. Synthecon offers products and services including RCCS 3D Cell Culture Systems, Stem Cell Culture Systems, Perfusion Bioreactors, and Custom Designed Bioreactors. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its legal entity is Synthecon, Incorporated. Its competitors include MaxCyte, SQZBiotech and Berkeley Lights; 3 of its 3 listed competitors have raised funding.
Company details
Synthecon was founded in 1990 in Houston, United States, and operates within the biotechnology sector. 3D cell culture systems are designed and manufactured, with the flagship Rotary Cell Culture System used for co-culturing multiple cell types in spheroid forms and precise flow control. Stem cell culture and perfusion systems are also produced, alongside nanobiomatrix and biostructure scaffolds for research applications.
- Headquarters Houston, United States
- SectorsHealthcareTechnology
- Website synthecon.com
- Social LinkedIn X Facebook
- Legal Name Synthecon, Incorporated
- Latest Funding Round$737.85K (USD), Grant
Apr 2009
- InvestorsHHS
& 1 more
Products & Services of Synthecon
Synthecon offers a comprehensive portfolio of products and services, including RCCS 3D Cell Culture Systems, Stem Cell Culture Systems, Perfusion Bioreactors, and Custom Designed Bioreactors.
Rotary system for 3D culturing of suspension cells in research.
Tools for cultivating stem cells in controlled environments.
Systems for continuous nutrient flow in cell culture applications.
Tailored bioreactors for specific research and tissue engineering needs.
Funding Insights of Synthecon
- Total Rounds 6
- Last Round Grant — $737,846
- First Round $737,846
(Mar 2003)
- Investors Count 2
All 6 funding rounds of Synthecon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2009 | $737,846 | Grant | – | – | |
| Jan 2009 | $100,000 | Grant | – | – | |
| Nov 2008 | $100,000 | Grant | – | – | |
| Sep 2008 | $908,578 | Grant | – | – | |
| Aug 2008 | $80,223 | Grant | – | – | |
| Mar 2003 | $737,846 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Synthecon
Synthecon has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Synthecon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Synthecon
3 dated milestones of Synthecon across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Synthecon is founded.
- Funding First funding round of $738K.
- Funding Latest funding round, Grant, of $738K.
Competitors of Synthecon
Synthecon has 3 listed competitors in our database, 3 of them funded. They include MaxCyte, SQZBiotech and Berkeley Lights.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| maxcyte.com | 1998 | Gaithersburg, United States | $20.69M | 71 | Instrument systems for cell processing and modification are provided. | |
| sqzbiotech.com | 2013 | Boston, United States | $167.41M | 117 | Cell therapies are developed using proprietary Cell Squeeze technology. | |
| berkeleylights.com | 2011 | Emeryville, United States | $124.72M | 267 | Microfluidics-based systems for single-cell isolation and analysis are developed. |
Detailed competitors of Synthecon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synthecon
The website of Synthecon (synthecon.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 16% vs previous month
Websites whose visitors overlap most with Synthecon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| chemometec.com | 100% | 31.8K | #992,798 | View details | |
oxford-optronix.com | oxford-optronix.com | 100% | #4,739,003 | – | |
brincubator.com | brincubator.com | 100% | – | ||
| flexcellint.com | 100% | #5,353,633 | View details | ||
| wavebiotech.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Synthecon
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Synthecon (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synthecon
Synthecon was founded in 1990 and raised its 1st funding round 13 years after it was founded.
Synthecon is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Synthecon was founded in 1990 in Houston, United States, and operates within the biotechnology sector. 3D cell culture systems are designed and manufactured, with the flagship Rotary Cell Culture System used for co-culturing multiple cell types in spheroid forms and precise flow control. Stem cell culture and perfusion systems are also produced, alongside nanobiomatrix and biostructure scaffolds for research applications.
Synthecon's top competitors include MaxCyte, SQZBiotech and Berkeley Lights.
Synthecon offers RCCS 3D Cell Culture Systems, Stem Cell Culture Systems, Perfusion Bioreactors, and Custom Designed Bioreactors.
Synthecon has 2 investors. Key investors include HHS, and National Science Foundation.
Synthecon operates through Synthecon, Incorporated.